Scholarlink

Abstract <p>A series of novel oxadiazole-imidazole scaffolds were successfully synthesized using a one-pot synthesis method. Thus, synthesized compounds were characterized by FT-IR, <sup>1</sup>H, <sup>13</sup>C NMR, and LC-MS techniques. The biological activities of these compounds are evaluated through in vitro studies, including anti-inflammatory activity assessed by the denaturation of bovine serum albumin (BSA) and antioxidant activity determined by the DPPH free radical scavenging assay. One of the compounds exhibited the most potent activity with IC<sub>50</sub> values of 25.5 µM for anti-inflammatory and 30.1 µM for antioxidant activity, surpassing the efficacy of standard drugs used in this investigation. Additionally, molecular docking studies were conducted using Human peroxiredoxin <b>5</b> revealing that the same compound demonstrated favorable binding interactions. These findings reveal that this compound is a promising candidate for further development as a drug-like candidate.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

One-Pot Synthesis of Oxadiazole-Imidazole Scaffolds: Anti-Inflammatory, Antioxidant Activity, Molecular Docking, Solvatochromism, and DFT Studies

  • 期刊论文

  • 发表日期：

    2025年10月31日

查看全文
  • Vardhaman Babagond,
  • Kariyappa Katagi,
  • Mahesh Akki,
  • Vinuta Kamat,
  • Ashwini Jaggal,
  • Surekha Kademani

摘要

Abstract

A series of novel oxadiazole-imidazole scaffolds were successfully synthesized using a one-pot synthesis method. Thus, synthesized compounds were characterized by FT-IR, 1H, 13C NMR, and LC-MS techniques. The biological activities of these compounds are evaluated through in vitro studies, including anti-inflammatory activity assessed by the denaturation of bovine serum albumin (BSA) and antioxidant activity determined by the DPPH free radical scavenging assay. One of the compounds exhibited the most potent activity with IC50 values of 25.5 µM for anti-inflammatory and 30.1 µM for antioxidant activity, surpassing the efficacy of standard drugs used in this investigation. Additionally, molecular docking studies were conducted using Human peroxiredoxin 5 revealing that the same compound demonstrated favorable binding interactions. These findings reveal that this compound is a promising candidate for further development as a drug-like candidate.